Page 1 of 5

British Journal of Healthcare and Medical Research - Vol. 11, No. 5

Publication Date: October 25, 2024

DOI:10.14738/bjhmr.115.17714.

Mahmood, A., Yaakovian, M., Ahmed, K., & Mahmood, A. M. (2024). Post Operative Pain Control Following Colon Resection – and

the Pendulum that has Swung from One Extreme to the Other. British Journal of Healthcare and Medical Research, Vol - 11(5). 129-

133.

Services for Science and Education – United Kingdom

Post Operative Pain Control Following Colon Resection – and the

Pendulum that has Swung from One Extreme to the Other

Ali Mahmood

Underwood Digestive Disease Center, Houston Methodist Hospital

Department of Surgery, Texas A&M School of Medicine 16605

Southwest Freeway, Suite 430, Sugar Land, TX 77479, USA

Michael Yaakovian

Houston Methodist Hospital, Department of Surgery

Houston Methodist Hospital, Institute of Academic Medicine

16605 Southwest Freeway, Suite 450, Sugar Land, TX 77479, USA

Kamran Ahmed

Houston Methodist Hospital, Department of Medicine

Kelsey, Seybold Clinic 11555 University Blvd, Sugar Land,

TX 77478, USA

Aiva Mariam Mahmood

Houston Methodist Hospital, Department of Surgery

16605 Southwest Freeway Suite 430, Sugar Land, TX 77479

USA

ABSTRACT

The mitigation and limitation of narcotics following colon resection procedures has

had many positive outcomes. The quicker return of bowel function has enabled

many patients to be discharged from the hospital sooner. Earlier return to home not

only provides the patients with a familiar environment to heal expediently, but also

limits their exposure to nosocomial infections and provides a financial savings to

healthcare. However, has the pendulum swung to far? Colon resection is a

tremendous trauma to the patient. Even laparoscopy requires a small incision to

extract the resected specimen, severing skin, muscle, fascia and peritoneum,

inciting visceral and somatic pain. While the volume of narcotics has been markedly

decreased, there is a role for narcotic usage in the post surgical colon resection

patient. There is real pain that is incurred by the patient following a laparoscopic

colon resection. Adequate control of this pain fosters an environment where the

patient is willing to ambulate more, motivated to push themselves to recovery and

build trust with their surgeons and caregivers. The purpose of our study was to

evaluate the efficacy of pain medication, in particular the pain medication

prescribed upon discharge. Our hypothesis centered around adequate and robust

pain control would result in a motivated patient enabling a faster return to pre- surgical quality of life and fewer narcotic refills. Appropriate care with potent

narcotics yields a more robust and faster recovery, with less refills on pain

medication and a shorter path to recovery.

Page 2 of 5

130

British Journal of Healthcare and Medical Research (BJHMR) Vol 11, Issue 05, October-2024

Services for Science and Education – United Kingdom

Keyword: Pain, Narcotics, Post-operative, Post-surgical, Enhanced Recovery

RESEARCH DESIGN

From January 2015 to January 2024, all patients that underwent a segmental colon resection

were identified. Patients that underwent an open procedure (laparoscopic converted to open)

were excluded from the study.

The type of pain management was identified. The duration of the PCA was recorded. The return

of bowel function and length of stay was recorded. The prescription for pain medication was

identified. The amount of refills authorized was reviewed. The patient’s return to work and/or

daily functional activity was extracted from the records.

RESULTS

There were 1608 colon resections identified. 62 (3.8%) were excluded due to them being

converted to an open procedure from a laparoscopic procedure. Patients were given a PCA.

1300 hundred patients had a dilaudid PCA for the first 24 hours. 244 had a morphine PCA. 2

patients had a fentanyl PCA. There were 2 patients that did not have their PCA discontinued in

the first 24 hours and they were excluded from the study.

Patients had a mean return of bowel function at 60.2 hours post operative ± 24 hours. Their

average length of stay was 4.3 days.

970 Patients that were given Norco 5/325 as their discharge pain medication. 322 patients

were given tramadol as their discharge pain medication. 248 patients were given Tylenol with

codeine (T3) as their discharge paid medication. 4 patients were given a regimen by their pain

management physician. They were excluded from the study.

Patients that received the Norco 5/325 had a much faster recovery. They returned to the work

setting, walking better and feeling better. The number of refills for the patient population

receiving robust pain control was markedly lower. Table 1 There were 0 patients that were

given a refill on the Norco. The patients on tramadol were not as progressive at the Norco

cohort. Of the 322, 52 patients (16%) asked for and received refills on their pain medication.

An additional 8 (2.5%) asked for a second refill. In the T3 patient cohort, 48 patients (19%)

asked for a refill upon return to their clinic follow up. An additional 12 (4.9%) patients

requested a second refill. From the Tramadol and T3 patient populations, of the 570 patients,

there were 12 patients, 2%, that asked for their leave of work to be extended. There were 0

patients from the Norco cohort that asked for a extension from returning to work.

The cohort of patients that received Norco 5/325 had an earlier return to daily functional

activity and/or work. The average time period from operation to returning to their occupation

was 19 days ± 3 days. There were two patients that were back to work 6 days after their

operation. These were excluded from the data because they were significant outliers. Patients

that were given tramadol returned to their daily functional activity, without any sequelae, 22

days ± 4 days, after their surgery. Patients that were given T3 had an average return to work

23 days ± 4 days.

Page 3 of 5

131

Mahmood, A., Yaakovian, M., Ahmed, K., & Mahmood, A. M. (2024). Post Operative Pain Control Following Colon Resection – and the Pendulum

that has Swung from One Extreme to the Other. British Journal of Healthcare and Medical Research, Vol - 11(5). 129-133.

URL: http://dx.doi.org/10.14738/bjhmr.115.17714.

DISCUSSION

The use of narcotics has been severely mitigated in the medical realm. While this has been

received with much positivity, there are instances and occurrences where the pendulum has

swung too far. Patients are expected to have pain following a major abdominal operation, with

an incision. While the authors of this study are not advocating for pain medicine to be

prescribed and dispensed blindly and carelessly, there definitely is an advantage to addressing

pain early and successfully following a colon resection.

Opioid dependency became an epidemic in healthcare. Some studies reported a 30% opioid

dependency stemming from hospital prescribed opioids. [1] There is also a cohort of patients

that enters the operation already on scheduled pain medication. These patients fare worse than

opioid naïve patients.[2] The tolerance to pain medication results in larger doses having to be

administered with poorer control. Younger patients have also been shown to report increased

pain, following major abdominal surgery.[3]

The use of laparoscopy has certainly helped with curtailing pain. The collective length at the

hospital has been shorter, along with the use of narcotics. [4] Some studies have shown that

using a Pfannenstiel incision, for colon extraction, versus a midline incision has reduced the

demand of narcotics. [5] The demand for opioids did not differ for benign versus malignant

pathology, for patients undergoing the same type of operation.[6]

Enhanced recovery after surgery (ERAS) protocols have played a monumental role in patients

leaving the hospital faster, requiring less pain medication and assimilating back into their daily

functional routine quicker. [7] One study showed the length of stay decreased from 6.7 to 3.7

days, the use of patient-controlled analgesia decreased from 63.2% to 15% and the duration of

narcotic usage decreased from 67.8 hours to 47.1 hours.[8] Some surgeons have used epidural

analgesia to augment narcotics, citing reduced postoperative pain. [9,10] Another study

advocated the use of intravenous lidocaine as an alternative to epidural bupivacaine in reducing

ileus duration, length of stay and post operative pain following colon resection. [11] The

authors of this study have not used epidural analgesia due to its potential for adverse effects,

complicating post operative recovery. The introduction of bupivacaine at the port sites has seen

some benefit with decreasing post operative narcotic usage, however these studies are varying

in their results. [12,13] Ultrasound and laparoscopic guided transversus abdominis plane

blocks received popularity in post operative pain control, mitigating the use of opioids. [14,15]

The Cochrane Database of Systemic Review illustrated that the use of ERAS with laparoscopy

decreased length of time for a bowel movement by 21.0%, with a 12.6% reduction in pain

scores. There was earlier resumption of an oral diet – (28.3% sooner) and patients were

discharged home 19.1% earlier.[16]

The results of our study showed that appropriate pain control early led to patients ambulating

better, assimilating back into their routines faster and gaining their confidence sooner. It is

paramount that patients ambulate early in the post operative course. Benefits include

prevention of blood clots, subsequent embolisms, pneumonia and aids in the bowel recovery

process, to name a few. The return to daily functional high functional activities, returning to

their profession, builds confidence and reinforces a successful recovery form a major operation.

Our study clearly demonstrated that return to work amongst the Norco cohort was faster on

average, when compared to tramadol or T3. Achieving robust pain control immediately upon